Next Article in Journal
Incomplete LPS Core-Specific Felix01-Like Virus vB_EcoM_VpaE1
Previous Article in Journal
Activation of the Mitochondrial Apoptotic Signaling Platform during Rubella Virus Infection
Article Menu

Export Article

Open AccessArticle

Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System

Laboratory of Retroviral Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4010 Debrecen, Hungary
Authors to whom correspondence should be addressed.
Academic Editor: Curt Hagedorn
Viruses 2015, 7(12), 6152-6162;
Received: 22 July 2015 / Revised: 11 November 2015 / Accepted: 13 November 2015 / Published: 27 November 2015
(This article belongs to the Section Antivirals & Vaccines)
PDF [583 KB, uploaded 27 November 2015]


Retroviral protease inhibitors (PIs) are fundamental pillars in the treatment of HIV infection and acquired immunodeficiency syndrome (AIDS). Currently used PIs are designed against HIV-1, and their effect on HIV-2 is understudied. Using a modular HIV-2 protease cassette system, inhibition profiling assays were carried out for protease inhibitors both in enzymatic and cell culture assays. Moreover, the treatment-associated resistance mutations (I54M, L90M) were introduced into the modular system, and comparative inhibition assays were performed to determine their effect on the susceptibility of the protease. Our results indicate that darunavir, saquinavir, indinavir and lopinavir were very effective HIV-2 protease inhibitors, while tipranavir, nelfinavir and amprenavir showed a decreased efficacy. I54M, L90M double mutation resulted in a significant reduction in the susceptibility to most of the inhibitors with the exception of tipranavir. To our knowledge, this modular system constitutes a novel approach in the field of HIV-2 protease characterization and susceptibility testing. View Full-Text
Keywords: HIV-2; protease; susceptibility; protease inhibitors; modular system HIV-2; protease; susceptibility; protease inhibitors; modular system

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Mahdi, M.; Szojka, Z.; Mótyán, J.A.; Tőzsér, J. Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System. Viruses 2015, 7, 6152-6162.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top